20 (AIDX) Current Assets (2024 - 2026)

20 (AIDX) reported Current Assets of $4.7 million for Q1 2026, up 219.5% quarter-over-quarter from $1.5 million in Q4 2025.

20 (AIDX) Current Assets (2024 - 2026) Analysis & Trends

20 has reported Current Assets for 3 years, with the latest figure at $4.7 million in Q1 2026.

  • For the quarter ending Q1 2026, Current Assets changed N/A year-over-year to $4.7 million; the trailing twelve-month figure through Mar 2026 stood at $4.7 million (changed N/A YoY), and the FY2025 full-year result was $1.5 million, down 27.68% from the prior year.
  • Current Assets for Q1 2026 stood at $4.7 million, up from $1.5 million in the prior quarter.
  • The five-year high for Current Assets was $4.7 million in Q1 2026, with the low at $1.5 million in Q4 2025.
  • Historically, Current Assets has averaged $2.7 million across 3 years, with a median of $2.0 million in 2024.
  • The largest YoY upside for Current Assets was 27.68% in 2025 against a maximum downside of 27.68% in 2025.
  • 20's Current Assets stood at $2.0 million in 2024, then retreated by 27.68% to $1.5 million in 2025, then soared by 219.5% to $4.7 million in 2026.
  • The last three Current Assets figures came in at $4.7 million (Q1 2026), $1.5 million (Q4 2025), and $2.0 million (Q4 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Assets (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn 25.51 Bn
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn 13.34 Bn
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn 24.07 Bn
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn 8.68 Bn
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn 6.23 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 11.45 Bn
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn 4.33 Bn
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn 10.43 Bn
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn 2.39 Bn
10 20 - - 62,884.00 4.70 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 4.70 Mn
Dec 31, 2025 1.47 Mn
Dec 31, 2024 2.03 Mn